Concepedia

Howard A. Cash

HA

11

Publications

1.1K

Citations

11

H-Index

1979

Active since

Affiliations

Ganeden Biotech (United States)(Current)

University of Verona

Case Western Reserve University

Beneficial Designs (United States)

University of Foggia

Howard A. Cash is an author at Ganeden Biotech (United States) specializing in medicine, microbiology, and clinical microbiology.

ORCID

Top concepts

Publications per year

1979–2019

11

Publications

11

A rat model of chronic respiratory infection with Pseudomonas aeruginosa.

Howard A. Cash, Donald E. Woods, B. D. McCullough et al. · PubMed · 1979 · 332 citations

, , +14

Once-Daily vs. Continuous Aminoglycoside Dosing: Efficacy and Toxicity in Animal and Clinical Studies of Gentamicin, Netilmicin, and Tobramycin

Stephen H. Powell, W. Leigh Thompson, M. A. Luthe et al. · The Journal of Infectious Diseases · 1983 · 275 citations

Integrate genome-based assessment of safety for probiotic strains: Bacillus coagulans GBI-30, 6086 as a case study

Elisa Salvetti, Luigi Orrù, Vittorio Capozzi et al. · Applied Microbiology and Biotechnology · 2016 · 108 citations

, , +7

Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women

Edna P. Nyangale, Sean Farmer, Howard A. Cash et al. · Journal of Nutrition · 2015 · 85 citations · Full text

, , +8

In vitro inhibition of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments

Ricardo U. Sorensen, Jeffrey D. Klinger, Howard A. Cash et al. · Infection and Immunity · 1983 · 66 citations · Full text

, , +13

Rows per page

1–5 of 11